Educational Review Systems, Inc. and Paradigm Medical Communications, LLC
Precision Medicine in Immuno-Oncology: The Evolving Role of Current and Emerging Biomarkers
| Overview / Abstract: |
Patient selection remains a major challenge for the field of immuno-oncology, and the role of biomarkers continues to evolve as new data are released and novel targets are identified. In addition, as the therapeutic landscape continues to change with new indications, combination regimens, and novel immuno-oncology agents, the role of biomarkers will continue to evolve. As a result, many oncology clinicians and pathologists have difficulty remaining up to date with the latest data and best practices. In addition, it is challenging for pathologists to keep current on optimal sample procurement, the use of circulating free tumor cells in lieu of tumor tissue, assay standardization, and which biomarker assays should be used. |
|
Expiration |
Mar 31, 2021 |
|
Discipline(s) |
Pharmacy CPE, Physician CME |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
1.5 |
|
Accreditation |
ACCME, ACPE |
|
Presenters / Authors / Faculty |
Michael J. Overman, MD Lynette M. Sholl, MD |
|
Activity Specialities / Related Topics |
Oncology / Cancer / Radiation Therapy, Pulmonary Medicine / COPD, Research |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Bristol-Myers Squibb. |
|
Keywords / Search Terms |
Paradigm Medical Communications, LLC. Biomarkers, oncology, research, immuno-oncology, cytotechnologists, pulmonologists, Free CE CME |
|